Retatrutide has a single Phase 2 dose-finding study with 338 total participants, no active comparator, and 48 weeks of follow-up
If oral tirzepatide costs $250/month but only produces 0.5% body weight loss per month (due to lower bioavailability), that is $500 per percentage point lost
We applied WHOs gender-specific obesity rates to those population estimates, then totaled them to arrive at a global obesity estimate
If you struggled through six months with minimal weight loss and persistent side effects, semaglutide may not be the right medication for you
Common causes include viral upper respiratory infections, bacterial pharyngitis (such as streptococcal infection), allergies, environmental irritants, or gastroesophageal reflux disease (GERD)
These are not small numbers